Lttl

The annual discount is smaller than the starting price suggests

Lttl publishes semaglutide injections at $99 monthly, $288 quarterly, $558 every six months or $1,068 annually. Tirzepatide is $149 monthly, $438 quarterly, $858 every six months or $1,668 annually. The $89/$139 starting figures belong to annual purchases; they are not the monthly auto-refill price.

The annual allocated rate is only $10 below the ordinary monthly amount for either injection. That is a modest reason to exchange flexibility for a larger payment. The site advertises the same price across doses, but the selected charge and renewal agreement still matter. Ask whether a promotional amount continues and whether changing formulation changes the quote.

For another monthly inquiry, yourEra advertises $89/$129 for new patients. That offer has its own continuing-price qualification. Compare both written quotes with the actual supply interval; the public monthly labels alone do not establish identical treatment, service or quantities.

Four weeks and a calendar month are different purchases

The plan selector labels monthly auto-refill a four-week supply, quarterly a twelve-week supply, six months a 24-week supply and annual a 52-week supply. Two stated six-month supplies therefore add to 48 weeks, not the annual label’s 52. The published calendar billing language does not explain how those intervals reconcile.

Six unchanged monthly charges would total $594 for semaglutide or $894 for tirzepatide, compared with the stated six-month package charges of $558/$858. That conditional arithmetic is not a confirmed six-calendar-month treatment budget. Obtain the debit dates, weekly dose count, vial quantity, concentration and usable dating together. We did not establish how shipments are divided or how titration changes the amount dispensed.

Microdose and dissolving tablets need their own clinical discussion

Both injectable microdose ladders show $149 monthly, $387 quarterly, $714 every six months or $1,308 annually. The plans selector additionally contains a $119 first-month promotion followed by $149 monthly. The same $119 is also a six-month plan’s allocated monthly rate, so ask which commitment a quoted figure describes.

The selector’s microdose semaglutide dissolving-tablet offer shows $149 initially then $179 monthly, or $477 quarterly, $894 every six months and $1,668 annually. Standard-dose oral tablet data also remains in the page source, but its product card is explicitly hidden; we would not present that dormant entry as a selectable offer. The microdose oral entry remains in the selector data, without patient-specific availability confirmed.

These are different preparations and purchase terms. A low-dose label does not establish better tolerability or a proven benefit for your circumstances, and injection evidence cannot establish tablet equivalence. Have the clinician explain the exact formulation, dose, administration and evidence before choosing the route. The compounded preparations are not FDA-approved; Lttl’s terms reject equivalence to branded products.

Medical rejection has conflicting refund language

The pricing page says a charge follows provider review and issuance of a treatment plan. It includes asynchronous assessment, care-team access, medication and pharmacy shipping. It also warns that applicable consultation fees may remain nonrefundable if no prescription is issued. No separate consultation amount or complete laboratory budget was established.

The May 12, 2026 terms instead promise a full refund for initial provider medical disqualification, except when disqualifying information was knowingly omitted or misrepresented. The refund page describes consultation fees as generally nonrefundable after review regardless of prescribing. Obtain a written rejection example showing any deduction, rather than assume all three descriptions mean every dollar comes back.

Cancel before the selected cutoff, not before delivery

The terms call prescription orders processed and nonrefundable once initial medical intake is submitted. The support refund page instead uses pharmacy processing for cancellation and separately prohibits medication refunds after shipment. Waiting for dispatch is therefore not a dependable grace period. Ask which earlier event governs your order.

Cancellation is available through hello@lttl.com, but the terms place the renewal deadline in checkout or the account without a public numerical cutoff. They require written refund requests within 28 days of payment; the support page gives 30 days for billing errors. Resolve the deadline before authorizing a charge. Damaged or incorrect shipments should be reported with photos within seven days, with replacement where appropriate.

For a prepaid purchase, ask how future renewal, remaining shipments and any unused balance are treated separately. Third-party financing carries its own repayment terms; installments do not establish a shorter treatment commitment.

A pharmacy list helps, but it is not your dispensing assignment

The terms identify The Commerce Group Holdings, LLC as platform operator and describe independent clinicians without naming the treating medical practice. They list RedRock Compounding Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx as possibilities, with transfers permitted for fulfillment, availability or pricing. Request your practice, prescriber and actual dispensing location.

A narrow official check found Triad Rx Buyer LLC, DBA Triad Rx, at the listed Daphne address: Oklahoma nonresident license 99-9913 was in good standing through April 30, 2027; its sterile-compounding field said No. Ohio listed the same entity/address as active under nonresident mail-order permit 022217500 through March 31, 2027. These are limited state-record observations, not evidence Triad will fill your order or can supply its proposed sterile preparation.

The Oklahoma record replaces older closed permits. A closed predecessor should not be mistaken for the current pharmacy’s status. Neither two permits nor a named network establishes all-state authorization, home-state status, batch quality or the credentials of your assigned clinician.

Confirm the location and the delivery clock together

The terms claim services in all fifty states plus Washington, DC, immediately qualified because particular services may be unavailable. Confirm the proposed medication and address rather than treating that footprint as individual eligibility. Shipping begins after prescription approval.

The banner promises prescribing and shipping within 48 hours; the terms say typically 48 business hours after approval. The shipping page instead allows two to five business days processing plus three to seven business days transit, with no guaranteed arrival. Plan around a confirmed pharmacy schedule, including signature and storage instructions, rather than the fastest headline.

Our recommendation: settle the basics before buying longer

We would start with a monthly injection quote if the clinician finds a compounded preparation appropriate, then revisit a longer purchase after the supply and refund answers are clear. Someone considering microdose or oral treatment needs an additional formulation-specific discussion; the menu is not evidence that those options are preferable.

Branded access should also be confirmed separately. The terms describe limited branded fulfillment subject to clinical approval and inventory, with medication costs paid by the patient; the pricing page mentions discussing an insured branded path. We did not establish a brand-specific price or available prescription. Neither a blanket promise of branded access nor an absolute claim that no branded path exists is justified.

This publisher review was revised October 25, 2026 using public sources. We did not enroll, submit health information, order medication or test care, delivery or refunds. The unresolved selected invoice, dispensing assignment and conflicting policies are the reasons our recommendation remains conditional.